Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/NovImmune

NovImmune

Series C
Plan-les-Ouates, SwitzerlandFounded 1998May 2009
Healthtech

NovImmune raised €41M in a Series C round in May 2009. The company is based in Plan-les-Ouates, Switzerland. Investors in the round: Aravis Ventures, BZ Bank, LODH Immunology Fund and 3 others. Data as of 4 Nov 2026.

← NovImmune
Amount raised
€41M
€41,280,603
Native amount
54,800,000 USD
Stage
Series C
series c
Investors
6

Provenance & confidence

Unverified
Amount
54,800,000 USD
ECB-at-date → €41M · rate 1.3275 on 2009-04-30
High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

6 named
Aravis VenturesBZ BankLODH Immunology FundNovartis Venture FundPictetVaruma
Date
May 2009
Round type
series c
Amount (EUR)
€41M

Other rounds

same company